The confirmed long-term success of lentiviral gene therapy for SCID establishes a clear blueprint for curing other monogenic pediatric disorders. Investigators are expanding this autologous delivery model to Wiskott-Aldrich syndrome, chronic granulomatous disease, and sickle cell anemia. With broader newborn screening identifying metabolic and immune deficiencies within days of birth, curative genetic corrections can now occur before damaging systemic infections take hold. For babies born without an immune system, sterile confinement is no longer a permanent refuge. It is merely a brief clinical stepping stone toward an ordinary, active life.
From 'Bubble Boy Disease' to Full Recovery: Groundbreaking Follow-up Shows Lasting Gene Therapy Cures
•
•
7 min read
